the Australian Securities Exchange Corporate Governance Council tracks gender diversity in its constituent companies. Japanese pharmaceutical company Takeda hit its target of 30 per cent ofnew managers being women (from only 6.2 per centin 2015) through a range of initiatives including flexible working h

iences Tissue Dynamics Lab on a chip Polypid Encapsulated drug delivery Sonorapy_ Soundwave diagnostics Protekt Memory-enhancing therapeutic (Takeda/FutureRx) RetiSpec Retinal Alzheimer diagnostics Oramed Injectable to oral therapy tech Pharmaceuticals Trea to Health data / social portal A

, industrial production +0.7% vs est +0.2% • Sony numbers look inline with recent revisions (guidance above consensus but a bit shy of whisper) • Takeda operating profit misses and full-year 2013/14 guidance well below consensus (out after close) • Nikon operating profit above consensus and guides f

unsch Senior Economics Editor Frankfurter Allgemeine Switzerland Zeitung Deborah Dunsire Chief Executive Officer and President Millennium: The Takeda USA Oncology Company Turgay Durak Chief Executive Officer Koc Holding AS Turkey Kelvin Dushnisky Senior Executive Vice-President Barrick Gol